Granulocytosis and thrombocytosis in renal cell carcinoma: a pro-inflammatory cytokine response originating in the tumour.

BACKGROUND In up to 20% of patients with renal cell cancer (RCC) an inflammatory response consisting of low-grade fever, weight loss and an elevated ESR and CRP may occur with modest granulocytosis and thrombocytosis. Clinical and experimental data suggest a pathogenic role for tumour-derived cytokine production, especially interleukin-6. CASE REPORT A 79-year-old female with RCC presented with low-grade fever, weight loss and overt granulocytosis and thrombocytosis. Radiological examination revealed a right-sided renal tumour. During nephrectomy a gradient between the IL-6 levels in the renal artery and vein was demonstrated, providing direct evidence for in vivo production of IL-6 by the tumour affected kidney, which was confirmed by the demonstration of IL -6 in the tumour cells by immunohistochemical staining and in the supernatant of the homogenised tumour. Cytogenetic examination revealed complex abnormalities including a gain of chromosome 7. In addition we demonstrated production of IL-1alpha, IL-1beta, IL-8 and ICAM-1 in the tumour with systemic elevated levels of IL-6 and IL-8 with secondary increased serum G-CSF and TPO levels. CONCLUSION We have provided direct evidence for the production of pro-inflammatory cytokines by renal cancer cells in a patient with RCC and a profound inflammatory response, with a central role of IL-6, probably due to a gain of chromosome 7. The extreme granulocytosis and thrombocytosis may have resulted from the secondary systemic production of G-CSF and TPO.

[1]  M. Guida,et al.  Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors , 2007, Journal of Translational Medicine.

[2]  M. Büchler,et al.  Characterization of Primary Renal Carcinoma Cultures , 2007, Urologia Internationalis.

[3]  C. Tzen,et al.  Renal cell carcinoma producing granulocyte colony-stimulating factor. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  A. Belldegrun,et al.  Interleukin-6 and renal cell cancer: Production, regulation, and growth effects , 2005, Cancer Immunology, Immunotherapy.

[5]  A. Meloni-Ehrig Renal cancer: cytogenetic and molecular genetic aspects. , 2002, American journal of medical genetics.

[6]  A. Ravaud,et al.  Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Razelle Kurzrock,et al.  Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53. , 2002, Cancer research.

[8]  G. Palapattu,et al.  Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. , 2002, Reviews in urology.

[9]  U. Andersson,et al.  Escherichia coli-induced expression of IL-1 alpha, IL-1 beta, IL-6 and IL-8 in normal human renal tubular epithelial cells. , 2001, Clinical and experimental immunology.

[10]  J. McNeal,et al.  Sarcomatoid Renal Cell Carcinoma of Papillary Origin , 2000 .

[11]  A. Ermens,et al.  Inverse relation between plasma G-CSF levels and neutrophil counts in a patient with autoimmune neutropenia treated with G-CSF. , 2000, Clinical and Laboratory Haematology.

[12]  U. Junker,et al.  Are renal cell carcinoma cells able to modulate the cytotoxic effect of tumor infiltrating lymphocytes by secretion of interleukin-6? , 1999, Anticancer research.

[13]  K. Grankvist,et al.  Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. , 1997, European journal of cancer.

[14]  J. Blay,et al.  Role of interleukin‐6 in the paraneoplastic inflammatory syndrome associated with renal‐cell carcinoma , 1997, International journal of cancer.

[15]  L. Rink,et al.  Cytokine production of neutrophils is limited to interleukin‐8 , 1996, Immunology.

[16]  S. Kagawa,et al.  A case of renal cell carcinoma producing granulocyte-macrophage colony-stimulating factor. , 1996, Journal of Urology.

[17]  É. Lepage,et al.  Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma. , 1994, European journal of cancer.

[18]  H. Imura,et al.  Thrombocytosis in patients with tumors producing colony-stimulating factor. , 1992, Blood.

[19]  T. Hirano,et al.  Enhanced expression of interleukin-6 in primary human renal cell carcinomas. , 1991, Journal of the National Cancer Institute.